Therapeutic Effect and Safety Evaluation of Naringin on Klebsiella pneumoniae in Mice
Description
Critically ill patients with Corona Virus Disease 2019 (COVID-19) often develop secondary bacterial infections that pose a significant threat to patient life safety, making the development of drugs to prevent bacterial infections in the lungs
